Inflammatory-associated proteomic predictors of cognitive outcome in subjects with ELVO treated by mechanical thrombectomy

Benton Maglinger, Jordan P. Harp, Jacqueline A. Frank, Chintan Rupareliya, Christopher J. McLouth, Shivani Pahwa, Lila Sheikhi, David Dornbos, Amanda L. Trout, Ann M. Stowe, Justin F. Fraser, Keith R. Pennypacker

Research output: Contribution to journalArticlepeer-review


Background: Emergent Large Vessel Occlusion (ELVO) stroke causes devastating vascular events which can lead to significant cognitive decline and dementia. In the subset of ELVO subjects treated with mechanical thrombectomy (MT) at our institution, we aimed to identify systemic and intracranial proteins predictive of cognitive function at time of discharge and at 90-days. These proteomic biomarkers may serve as prognostic indicators of recovery, as well as potential targets for novel/existing therapeutics to be delivered during the subacute stage of stroke recovery. Methods: At the University of Kentucky Center for Advanced Translational Stroke Sciences, the BACTRAC tissue registry (; NCT 03153683) of human biospecimens acquired during ELVO stroke by MT is utilized for research. Clinical data are collected on each enrolled subject who meets inclusion criteria. Blood samples obtained during thrombectomy were sent to Olink Proteomics for proteomic expression values. Montreal Cognitive Assessments (MoCA) were evaluated with categorical variables using ANOVA and t-tests, and continuous variables using Pearson correlations. Results: There were n = 52 subjects with discharge MoCA scores and n = 28 subjects with 90-day MoCA scores. Several systemic and intracranial proteins were identified as having significant correlations to discharge MoCA scores as well as 90-day MoCA scores. Highlighted proteins included s-DPP4, CCL11, IGFBP3, DNER, NRP1, MCP1, and COMP. Conclusion: We set out to identify proteomic predictors and potential therapeutic targets related to cognitive outcomes in ELVO subjects undergoing MT. Here, we identify several proteins which predicted MoCA after MT, which may serve as therapeutic targets to lessen post-stroke cognitive decline.

Original languageEnglish
Article number214
JournalBMC Neurology
Issue number1
StatePublished - Dec 2023

Bibliographical note

Publisher Copyright:
© 2023, The Author(s).


  • Biomarkers
  • Ischemic stroke
  • Mechanical thrombectomy
  • Proteomics

ASJC Scopus subject areas

  • Clinical Neurology


Dive into the research topics of 'Inflammatory-associated proteomic predictors of cognitive outcome in subjects with ELVO treated by mechanical thrombectomy'. Together they form a unique fingerprint.

Cite this